— Know what they know.
Not Investment Advice

MGRM NASDAQ

Monogram Orthopaedics, Inc.
1W: +1.7% 1M: +4.0% 3M: +81.3% 1Y: +158.6%
$6.00
Last traded 2025-10-08 — delisted
NASDAQ · Healthcare · Medical - Devices · $243.8M mcap · 18M float · 2.22% daily turnover · Short 18% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$243.8M
52W Range1.918-6.425
Volume1,777,205
Avg Volume409,631
Beta0.69
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOBenjamin Sexson
Employees27
SectorHealthcare
IndustryMedical - Devices
IPO Date2023-05-18
3913 Todd Lane
Austin, TX 78744
US
512 399 2656
About Monogram Orthopaedics, Inc.

Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Gray Colleen 3,000 $4.00 2025-10-14
Gray Colleen D-Return 8,000 — 2025-10-07
Van Kirk Richard Lee D-Return 7,000 — 2025-10-07
Unis Douglas D-Return 1,475,000 — 2025-10-07
Unis Douglas D-Return 3,532,622 $4.04 2025-10-07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms